China National Medicines Corporation Ltd.
Overview
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company provides nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and cefoperazone dispersible tablets; and cefuroxime axetil tablets, cefuroxime sodium for injection, ce
Employees9697
Market Cap$11.9B
Revenue$8.8B
Listed OnShanghai Stock Exchange
Ticker600420
CEOMr. Yong Liu
HeadquartersShanghai